Sylatron Drug Interactions
Currently displaying a list of 228 drugs known to interact with Sylatron (peginterferon alfa-2b).
- 41 major drug interactions
- 183 moderate drug interactions
- 4 minor drug interactions
Medications known to interact with Sylatron
Note: Showing generic names only.
- adalimumab
- ado-trastuzumab emtansine
- alemtuzumab
- amifampridine
- aminophylline
- amiodarone
- anisindione
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atezolizumab
- atorvastatin
- auranofin
- aurothioglucose
- avatrombopag
- avelumab
- axicabtagene ciloleucel
- azathioprine
- baricitinib
- bedaquiline
- benznidazole
- bexarotene
- black cohosh
- bortezomib
- brentuximab
- brexucabtagene autoleucel
- bupropion
- cabazitaxel
- calaspargase pegol
- cannabidiol
- carboplatin
- carfilzomib
- cemiplimab
- cerivastatin
- certolizumab
- chloramphenicol
- chloramphenicol ophthalmic
- chloramphenicol otic
- chloroquine
- ciltacabtagene autoleucel
- cisplatin
- cladribine
- clofarabine
- clozapine
- colchicine
- cosibelimab
- crizotinib
- cyclophosphamide
- daclizumab
- dapsone
- deferiprone
- denosumab
- deucravacitinib
- dicumarol
- didanosine
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- disulfiram
- docetaxel
- dostarlimab
- doxorubicin
- doxorubicin liposomal
- durvalumab
- efavirenz
- efbemalenograstim alfa
- eflapegrastim
- elotuzumab
- elranatamab
- eltrombopag
- enfortumab vedotin
- epirubicin
- eribulin
- etanercept
- ethambutol
- ethionamide
- etoposide
- etranacogene dezaparvovec
- etrasimod
- etravirine
- evening primrose
- fenfluramine
- fezolinetant
- fidanacogene elaparvovec
- filgrastim
- fingolimod
- fludarabine
- fluphenazine
- fluvastatin
- idecabtagene vicleucel
- idelalisib
- infliximab
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- interferon beta-1a
- interferon beta-1b
- iodoquinol
- iohexol
- iomeprol
- iopamidol
- ipilimumab
- isoniazid
- ixabepilone
- ixazomib
- leflunomide
- levodopa
- levoketoconazole
- lindane topical
- linezolid
- lisocabtagene maraleucel
- lomitapide
- loncastuximab tesirine
- lovastatin
- melatonin
- methadone
- methotrexate
- metrizamide
- metronidazole
- mipomersen
- mirvetuximab soravtansine
- monomethyl fumarate
- mosunetuzumab
- paclitaxel
- paclitaxel protein-bound
- palifermin
- pegaspargase
- pegfilgrastim
- peginterferon alfa-2a
- peginterferon beta-1a
- pegloticase
- pegvaliase
- pembrolizumab
- penpulimab
- pexidartinib
- pimozide
- pitavastatin
- pitolisant
- polatuzumab vedotin
- polyethylene glycol 3350 with electrolytes
- pomalidomide
- ponatinib
- ponesimod
- pravastatin
- radium 223 dichloride
- ramelteon
- rasagiline
- red yeast rice
- remdesivir
- repotrectinib
- retifanlimab
- rifampin
- ritlecitinib
- roflumilast
- roflumilast topical
- ropeginterferon alfa-2b
- ropinirole
- rosuvastatin
- samarium sm 153 lexidronam
- sargramostim
- secnidazole
- selinexor
- simvastatin
- siponimod
- sipuleucel-T
- sodium phosphate p32
- stavudine
- stiripentol
- strontium-89 chloride
- talquetamab
- tarlatamab
- tbo-filgrastim
- teclistamab
- telbivudine
- teniposide
- teriflunomide
- thalidomide
- theophylline
- thioguanine
- tinidazole
- tisagenlecleucel
- tislelizumab
- tisotumab vedotin
- tizanidine
- tocilizumab
- tofacitinib
- topotecan
- toripalimab
- trabectedin
- tramadol
- tremelimumab
- valganciclovir
- valoctocogene roxaparvovec
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voclosporin
Sylatron disease interactions
There are 20 disease interactions with Sylatron (peginterferon alfa-2b) which include:
- renal dysfunction
- autoimmune diseases
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- autoimmune hepatitis
- depression
- severe hepatic disease
- hemoglobinopathies
- renal dysfunction
- colitis
- diabetes mellitus
- myelosuppression
- peripheral neuropathy
- bone marrow suppression
- endocrine disorders
- ophthalmological disorders
- pancreatitis
- pulmonary disorders
Report options
More about Sylatron (peginterferon alfa-2b)
- Sylatron consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antineoplastic interferons
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Tecentriq
Tecentriq (atezolizumab) is a monoclonal antibody used to treat non-small cell lung cancer, small ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Opdualag
Opdualag (nivolumab and relatlimab-rmbw) is used for the treatment of unresectable or metastatic ...
Interferon alfa-2b
Interferon alfa-2b is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated ...
Dacarbazine
Dacarbazine is used for hodgkin's lymphoma, melanoma, melanoma, metastatic
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.